BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-21 out of 21 found
  Current Search:  urticaria: 21, pigmentosa: 23     

HTML
50%
Contact urticaria to raw potato
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Dermatology Online Journal, 06/25/09 Print Save in My Library Free Full Text Lagran ZMD et al.

- Although potatoes represent a large part of diets...

MDLinx:  Jun 25 2009 1:08PM
Matching: urticaria
Find similar documents
HTML
50%
Levetiracetam Induced Interstitial Nephritis and Renal Failure
Save in My Library Free Abstract Hurwitz KA et al.

- A 17-year-old girl who had started on levetiracetam because of new onset partial complex seizures developed acute renal failure and biopsy-confirmed interstitial nephritis 10 days after...

MDLinx:  Jun 25 2009 11:31AM
Matching: urticaria
Find similar documents
HTML
50%
EMEA grants Clinuvel new orphan drug designation Committee for Orphan Medical Products (COMP) issues positive
Melbourne, Australia, 18th June, 2009 --Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) is pleased to announce that afamelanotide, its photoprotective drug, has been granted Orphan Medicinal Product (OMP) designation...
Pharma Live:  Jun 24 2009 3:27AM
Matching: urticaria
Find similar documents
HTML
50%
Knocking The Wind Out Of Asthmatics: Help From Hippocrates
Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects.

Further respiratory...

Medical News Today:  Jun 23 2009 8:36AM
Matching: urticaria
Find similar documents
HTML
50%
Knocking the Wind Out of Asthmatics: Help from Hippocrates
Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular...
KSLA:  Jun 23 2009 2:15AM
Matching: urticaria
Find similar documents
HTML
50%
Knocking the Wind Out of Asthmatics: Help from Hippocrates
Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular...
Montana's News Station:  Jun 22 2009 11:50PM
Matching: urticaria
Find similar documents
HTML
50%
Knocking the Wind Out of Asthmatics: Help from Hippocrates
Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular...
KOTA Territory News:  Jun 22 2009 12:50PM
Matching: urticaria
Find similar documents
HTML
50%
Knocking the Wind Out of Asthmatics: Help from Hippocrates
Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland What's an allergy sufferer to do?

The manufacturers of the ALCAT Test, a food intolerance test, suggest going back to Hippocrates'...

Genetic Engineering News:  Jun 22 2009 10:48AM
Matching: urticaria
Find similar documents
HTML
50%
EMEA Grants Clinuvel New Orphan Drug - For Solar Urticaria - Designation
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) is pleased to announce that afamelanotide, its photoprotective drug, has been granted Orphan Medicinal Product (OMP) designation by the European Medicines Agency (EMEA)...
Medical News Today:  Jun 19 2009 1:11PM
Matching: urticaria
Find similar documents
HTML
50%
Update Module 1482: Drug-induced skin reactions
When faced with a skin complaint, how can you tell if its drug-induced?

Skin reactions caused by medicines can be difficult to distinguish from normal skin conditions, so find out if the problem coincided with new medication?

Most drug...

Chemist+Druggist:  Jun 19 2009 10:24AM
Matching: urticaria
Find similar documents
HTML
50%
Clinuvel's drug gets OMP status in Europe to treat solar urticaria
: Australia's Clinuvel Pharmaceuticals said that its photoprotective drug, afamelanotide, has been granted Orphan Medicinal Product (OMP) designation by the European Medicines Agency (EMEA) for the treatment of solar urticaria (SU).
Bio Spectrum Asia:  Jun 18 2009 6:14AM
Matching: urticaria
Find similar documents
HTML
50%
Clinuvel awarded orphan drug status by EU
Clinuvel Pharmaceuticals has received Orphan Medical Product (OMP) designation by the European Medicines Agency (EMEA) for its drug, afamelanotide, for the treatment of solar urticaria (SU).

OMP designation provides regulatory...

Biotechnology News:  Jun 18 2009 3:23AM
Matching: urticaria
Find similar documents
HTML
50%
Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg
Today in Derm Allergy/Immunology...

Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg.

MDLinx:  Jun 15 2009 7:34PM
Matching: urticaria
Find similar documents
HTML
50%
Product news (13 June 2009)
Eye drop suspension.

Non-steroidal anti-inflammatory pro-drug.

Prevention and treatment of postoperative pain and inflammation associated with cataract surgery.

In adults one drop in the conjunctival sac of the affected eye(s) three...

PJ Online:  Jun 11 2009 10:53AM
Matching: urticaria
Find similar documents
HTML
50%
New antihistamine launched
Rupatadine (Rupafin), a second-generation antihistamine, has been launched by GlaxoSmithKline.

Rupatidine is a long acting histamine antagonist with selective peripheral H1-receptor antagonist activity for the treatment of allergic...

PJ Online:  Jun 11 2009 5:08PM
Matching: urticaria
Find similar documents
HTML
50%
Acute Urticaria and Angioedema: Diagnostic and Treatment Considerations
Today in Derm Allergy/Immunology...

Acute Urticaria and Angioedema: Diagnostic and Treatment Considerations.

MDLinx:  Jun 9 2009 10:20PM
Matching: urticaria
Find similar documents
HTML
50%
Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in
Clinical Data Presented at the 2009 ASCO Meeting INDIANAPOLIS, May 30 /PRNewswire/ -- Semafore Pharmaceuticals, Inc., a privately held cancer drug discovery and development company, today presented data from a Phase I clinical trial of its...
Pharmacy Choice:  May 31 2009 4:07PM
Matching: urticaria
Find similar documents
HTML
50%
Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in
Clinical Data Presented at the 2009 ASCO Meeting INDIANAPOLIS, May 30 /PRNewswire/ -- Semafore Pharmaceuticals, Inc., a privately held cancer drug discovery and development company, today presented data from a Phase I clinical trial of its...
KLFY:  May 31 2009 6:46AM
Matching: urticaria
Find similar documents
HTML
50%
Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in
Clinical Data Presented at the 2009 ASCO Meeting ) INDIANAPOLIS, May 30, 2009 /PRNewswire via COMTEX/ -- Semafore Pharmaceuticals, Inc., a privately held cancer drug discovery and development company, today presented data from a Phase I...
RBC Dain Raushcer:  May 31 2009 6:39AM
Matching: urticaria
Find similar documents
HTML
50%
Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in
Clinical Data Presented at the 2009 ASCO Meeting INDIANAPOLIS, May 30 /PRNewswire/ -- Semafore Pharmaceuticals, Inc., a privately held cancer drug discovery and development company, today presented data from a Phase I clinical trial of its...
Montana's News Station:  May 30 2009 6:23PM
Matching: urticaria
Find similar documents
HTML
50%
Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in
Clinical Data Presented at the 2009 ASCO Meeting INDIANAPOLIS, May 30 /PRNewswire/ -- Semafore Pharmaceuticals, Inc., a privately held cancer drug discovery and development company, today presented data from a Phase I clinical trial of its...
KSLA:  May 30 2009 3:48PM
Matching: urticaria
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.